Johnson & Johnson Looks To Sell Diagnostics UnitVW Staff
Johnson & Johnson (NYSE:JNJ) is readying financial information and legal forms in order to sell one of its diagnostics businesses. Dow Jones reported that the diversified healthcare company has JPMorgan Chase & Co (NYSE:JPM) advising it on the sale, and the business could fetch as much as $5 billion.
exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email firstname.lastname@example.org and we will get back to you as quick as humanly possible